Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction
- 1 January 2005
- journal article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology
- Vol. 38 (1) , 127-134
- https://doi.org/10.1016/j.yjmcc.2004.10.006
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Infarct size limitation by nicorandilJournal of the American College of Cardiology, 2002
- p38 MAP kinase is a mediator of ischemic preconditioning in pigs.Cardiovascular Research, 2002
- Carbon Monoxide: Innovative Anti-inflammatory Properties of an Age-Old Gas MoleculeAntioxidants and Redox Signaling, 2002
- Carbon Monoxide Protects Pancreatic β-Cells From Apoptosis and Improves Islet Function/Survival After TransplantationDiabetes, 2002
- Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathwayHepatology, 2002
- Carbon Monoxide-Releasing MoleculesCirculation Research, 2002
- Nitroglycerin induces late preconditioning against myocardial infarction in conscious rabbits despite development of nitrate tolerance.Circulation, 2001
- Activation of Mitochondrial K ATP Channel Elicits Late Preconditioning Against Myocardial Infarction via Protein Kinase C Signaling PathwayCirculation Research, 1999
- The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase geneProceedings of the National Academy of Sciences, 1999
- Ischemic preconditioning limits infarct size following regional ischemia–reperfusion in in situ mouse heartsCardiovascular Research, 1999